RESUMEN
PURPOSE: To evaluate genetic damage and oxidative stress following a single therapeutic dose of 131I in Graves' disease patients monitored up to 180 days after treatment. MATERIALS AND METHODS: Genetic damage induction was estimated as the increase in micronuclei in peripheral lymphocytes of patients. As indicators of radiogenic oxidative stress, vitamin E and lipoperoxide levels were assessed in the plasma of patients, as well as the release of plasmic clastogenic factors measured by the induction of micronuclei in vitro in peripheral lymphocytes of a healthy donor. RESULTS: Vitamin E depletion lasted at least 3 days and the basal level was restored within 7 days. No statistically significant variations were observed in lipoperoxide plasma levels. A sharp increase of micronuclei in the peripheral lymphocytes of patients was correlated (p < 0.001) with the release of clastogenic factor in the plasma. The highest micronucleus value was negatively correlated (p < 0.03) with the lowest vitamin E level observed in each patient. CONCLUSIONS: Micronuclei induction was the direct consequence not only of the energy deposition of 131I on the genetic material, but also of oxidative stress, likely via the release of clastogenic factor.
Asunto(s)
Daño del ADN/efectos de la radiación , Enfermedad de Graves/radioterapia , Radioisótopos de Yodo/efectos adversos , Estrés Oxidativo/efectos de la radiación , Adulto , Anciano , Femenino , Humanos , Peróxidos Lipídicos/efectos de la radiación , Linfocitos/efectos de la radiación , Masculino , Micronúcleos con Defecto Cromosómico/efectos de la radiación , Persona de Mediana Edad , Vitamina E/efectos de la radiaciónRESUMEN
Activation of acid and neutral sphingomyelinases, and the ensuing generation of ceramide, contributes to the biological effects of tumour necrosis factor-alpha (TNF-alpha), one of which is apoptosis. While the mechanisms of activation of sphingomyelinases by the cytokine are being unravelled, less is known about regulation of their activity. Nitric oxide has previously been shown to exert a cyclic GMP-dependent inhibition of early apoptotic events triggered by TNF-alpha in the U937 monocytic cell line. We therefore investigated whether inhibition of sphingomyelinases by nitric oxide plays a role in regulating such early events. We found that activation of both acid and neutral sphingomyelinases, triggered in the first minutes after U937 cell stimulation with TNF-alpha, is regulated in an inhibitory fashion by nitric oxide, working through generation of cyclic GMP and activation of protein kinase G. Using a range of inhibitors selective for either sphingomyelinase we found that the acid sphingomyelinase contributes to activation of the initiator caspase-8 and early DNA fragmentation and that inhibition of the acid enzyme by nitric oxide accounts for cyclic GMP-dependent early protection from apoptosis. We also found that the protective effect by both cGMP and acid sphingomyelinase inhibitors progressively disappeared at later stages of the apoptotic process. Inhibition of sphingomyelinases represents a novel action of nitric oxide, which might be of physiological relevance in regulating initial phases of apoptosis as well as other biological actions of ceramide.
Asunto(s)
Apoptosis/fisiología , GMP Cíclico/metabolismo , Óxido Nítrico/metabolismo , Esfingomielina Fosfodiesterasa/metabolismo , Apoptosis/efectos de los fármacos , Cicloheximida/farmacología , Humanos , Inhibidores de la Síntesis de la Proteína/farmacología , Esfingomielina Fosfodiesterasa/antagonistas & inhibidores , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
BACKGROUND/AIMS: No experimental study has clearly demonstrated how liver necrosis worsens the evolution of fulminant hepatic failure. Considering that several types of liver injury are associated with oxidative stress, we decided to measure plasma oxidative markers in two pig models of fulminant hepatic failure without and with liver necrosis. METHODOLOGY: Fulminant hepatic failure was produced in two groups of six pigs each by either total hepatectomy or complete hepatic devascularization. The following parameters were recorded before and during the course of hepatic failure: electrocerebral activity, plasma vitamin E, malondialdehyde and fluorescent protein-aldehyde adducts, total cholesterol, lactate-dehydrogenase, creatine phosphokinase, and ammonium. RESULTS: Despite comparable survival periods, hepatic necrosis was associated with earlier electrocerebral deterioration. Plasma concentration of malondialdehyde and fluorescent protein-aldehyde adducts rose and vitamin E content decreased in both groups. However, while in the group without liver necrosis the rates of cholesterol and vitamin E decay were identical, in the group with liver necrosis cholesterol concentration decreased less than vitamin E concentration, strongly indicating a true intravascular oxidation of vitamin E. Interestingly, in both models the rise of oxidative parameters preceded the development of cell injury. CONCLUSIONS: Oxidative stress, although present in both models, was significantly higher in the group with liver necrosis.
Asunto(s)
Electroencefalografía , Encefalopatía Hepática/fisiopatología , Cirrosis Hepática Experimental/fisiopatología , Pruebas de Función Hepática , Estrés Oxidativo/fisiología , Animales , Corteza Cerebral/fisiopatología , Colesterol/sangre , Creatina Quinasa/sangre , Aductos de ADN/sangre , Modelos Animales de Enfermedad , L-Lactato Deshidrogenasa/sangre , Hígado/fisiopatología , Malondialdehído/sangre , Compuestos de Amonio Cuaternario/sangre , Porcinos , Vitamina E/sangreRESUMEN
Cell death via apoptosis induced by tumor necrosis factor-alpha (TNF-alpha) plays an important role in many physiological and pathological conditions. The signal transduction pathway activated by this cytokine is known to be regulated by several intracellular messengers. In particular, in many systems nitric oxide (NO) has been shown to protect cells from TNF-alpha-induced apoptosis. However, whether NO can be generated by the cytokine to down-regulate its own apoptotic program has never been studied. We have addressed this question in HeLa Tet-off cell clones stably transfected with the endothelial NO synthase under a tetracycline-responsive promoter. Endothelial NO synthase, induced about 100-fold in these cells by removal of the antibiotic, retained the characteristics of the native enzyme of endothelial cells, both in terms of intracellular localization and functional activity. Expression of the endothelial NO synthase was sufficient to protect from TNF-alpha-induced apoptosis. This protection was mediated by the generation of NO. TNF-alpha itself stimulated endothelial NO synthase activity to generate NO through a pathway involving its lipid messenger, ceramide. Our results identify a novel mechanism of regulation of a signal transduction pathway activated by death receptors and suggest that NO may constitute a built-in mechanism by which TNF-alpha controls its own apoptotic program.
Asunto(s)
Apoptosis/efectos de los fármacos , Óxido Nítrico Sintasa/efectos de los fármacos , Factor de Necrosis Tumoral alfa/farmacología , Adenosina Trifosfato/farmacología , GMP Cíclico/biosíntesis , Cicloheximida/farmacología , Activación Enzimática/efectos de los fármacos , Retroalimentación , Células HeLa , Humanos , Morfolinas/farmacología , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico/biosíntesis , Óxido Nítrico Sintasa/genética , Óxido Nítrico Sintasa de Tipo IIIRESUMEN
We sought to test the hypothesis of an antioxidant effect of dipyridamole in vivo in a model of cerebral hypoperfusion. Twenty-one patients (65+/-10 years, 11 men) undergoing carotid endarterectomy were allocated in two groups (group 1, 10 with dipyridamole, 200 mg p.o., 3-4 h before surgery; group II, 11 with placebo) in a double-blind placebo-controlled randomized design. Blood was sampled from ipsilateral jugular bulb, and plasma vitamin E content was assayed before, after 15 and 30 min of clamp, and 2 and 10 min after declamping. In 12 of them, lipoperoxides were assayed. Vitamin E plasma content decreased significantly in group II (rest, 3.71+/-0.22 mmol/mol of cholesterol, 100%) after clamp (91.5% of rest, p < 0.01) and remained unchanged during declamping (90.9% of rest, p < 0.01), but did not change in group I (rest, 3.5+/-0.44 mmol/mol of cholesterol, 100%) during clamping (99.9% of rest; p = NS) and after declamping (97.6% of rest; p = NS). Lipoperoxide concentration did not change in group I (rest, 302+/-8 a.u.; clamp, 296+/-13 a.u.; p = NS vs. rest; declamp, 304+/-8 a.u.; p = NS vs. rest), and increased significantly in group II (rest, 313+/-5 a.u.; clamp, 352+/-9 a.u.; p < 0.01 vs. rest; declamp, 343+/-6 a.u.; p < 0.05 vs. rest). Cerebral oxidative stress associated with human carotid endarterectomy can be attenuated by pretreatment with oral dipyridamole.
Asunto(s)
Antioxidantes/farmacología , Circulación Cerebrovascular/efectos de los fármacos , Dipiridamol/farmacología , Endarterectomía Carotidea/efectos adversos , Vasodilatadores/farmacología , Anciano , Colesterol/sangre , Método Doble Ciego , Potenciales Evocados Somatosensoriales/efectos de los fármacos , Femenino , Humanos , Peroxidación de Lípido/efectos de los fármacos , Masculino , Persona de Mediana Edad , Ultrasonografía Doppler Transcraneal , Vitamina E/sangreRESUMEN
OBJECTIVE: To test the antioxidant effect of therapeutic doses of dipyridamole on cellular membranes, human erythrocytes were chosen as an appropriate model to study oxidative stress induced by cumene hydroperoxide because of their high content in heme-Fe(2+). METHODS: The oxidative stress was induced by incubation with 160 micromoll(-1) cumene hydroperoxide and expressed by three main factors: lipid peroxidation by means of kinetics of decrease in fluorescence emission of the probe incorporated in the cell membranes, vitamin E oxidation and intracellular thiol content. The concentrations of dipyridamole tested (2-20 micromoll(-1)) did not exceed pharmacological doses. RESULTS: After 7 min of incubation at 25 degrees C with the oxidant and 20 micromoll(-1) dipyridamole thiol content was 50.1%+/-2.6 compared with 31.5%+/-2.4 in the absence of the drug. After 12 min vitamin E content was 88.3%+/-2.3 compared with 64.7%+/-3.4 of untreated cells in the absence of dipyridamole. Dipyridamole added 5 min after the oxidation reaction suppressed the fluorescence decrease for a time proportional to the drug concentration. CONCLUSIONS: Thus, at clinically realistic doses dipyridamole shows a concentration-dependent antioxidant effect. It protects membranes from oxidation and spares the antioxidant power of erythrocytes.
Asunto(s)
Antioxidantes/farmacología , Dipiridamol/farmacología , Eritrocitos/metabolismo , Estrés Oxidativo , Compuestos de Sulfhidrilo/metabolismo , Vitamina E/metabolismo , Derivados del Benceno , Cromatografía Líquida de Alta Presión , Citosol/metabolismo , Relación Dosis-Respuesta a Droga , Membrana Eritrocítica/metabolismo , Eritrocitos/efectos de los fármacos , Humanos , Peroxidación de Lípido/efectos de los fármacos , Vitamina E/análisisRESUMEN
Apoptosis triggered by death receptors proceeds after defined signal-transduction pathways. Whether signaling at the receptor level is regulated by intracellular messengers is still unknown. We have investigated the role of two messengers, ceramide and nitric oxide (NO), on the apoptotic pathway activated in human monocytic U937 cells by tumor necrosis factor-alpha (TNF-alpha) working at its p55 receptor. Two transduction events, the receptor recruitment of the adapter protein, TRADD, and the activation of the initiator caspase, caspase 8, were investigated. When administered alone, neither of the messengers had any effect on these events. In combination with TNF-alpha, however, ceramide potentiated, whereas NO inhibited, TNF-alpha-induced TRADD recruitment and caspase 8 activity. The effect of NO, which was cGMP-dependent, was due to inhibition of the TNF-alpha-induced generation of ceramide. Our results identify a mechanism of regulation of a signal-transduction pathway activated by death receptors.
Asunto(s)
Apoptosis/fisiología , Ceramidas/metabolismo , Óxido Nítrico/fisiología , Penicilamina/análogos & derivados , Factor de Necrosis Tumoral alfa/farmacología , Antígenos CD/fisiología , Apoptosis/efectos de los fármacos , Caspasa 8 , Caspasa 9 , Caspasas/metabolismo , GMP Cíclico/análogos & derivados , GMP Cíclico/farmacología , GMP Cíclico/fisiología , Inhibidores Enzimáticos/farmacología , Humanos , Cinética , Donantes de Óxido Nítrico/farmacología , Oxadiazoles/farmacología , Penicilamina/farmacología , Proteínas/metabolismo , Quinoxalinas/farmacología , Receptores del Factor de Necrosis Tumoral/fisiología , Receptores Tipo I de Factores de Necrosis Tumoral , S-Nitroso-N-Acetilpenicilamina , Sistemas de Mensajero Secundario , Transducción de Señal , Esfingosina/análogos & derivados , Esfingosina/farmacología , Factor 1 Asociado a Receptor de TNF , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Factor de Necrosis Tumoral alfa/farmacocinética , Células U937RESUMEN
The role of the Ca(2+)-activated tyrosine kinase, Pyk2, in the pleiotropic coupling of nerve cell stimulation to the MAP kinase cascade still remains undefined. Using a panel of PC12 clones, one of which was defective in Pyk2, we demonstrate (1) that the MAP kinase response induced by a [Ca(2+)](i) rise (following application of the Ca(2+) ionophore, ionomycin) is inappreciable in the defective clone and is re-established after Pyk2 transfection; and (2) that the responses to both protein kinase C and P(2y2) receptor activation occur normally even in the defective cells. We conclude that Pyk2 is the key mediator in the pathway activated by Ca(2+) but has minor roles with the other types of stimulation.
Asunto(s)
Calcio/farmacología , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Proteínas del Tejido Nervioso/fisiología , Neuronas/efectos de los fármacos , Proteína Quinasa C/farmacología , Proteínas Tirosina Quinasas/fisiología , Adenosina Trifosfato/metabolismo , Animales , Calmodulina/antagonistas & inhibidores , Quelantes/farmacología , Ácido Egtácico/análogos & derivados , Ácido Egtácico/farmacología , Quinasa 2 de Adhesión Focal , Ionomicina/farmacología , Ionóforos/farmacología , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Neuronas/metabolismo , Células PC12/efectos de los fármacos , Células PC12/metabolismo , Fosforilación/efectos de los fármacos , Procesamiento Proteico-Postraduccional/efectos de los fármacos , Ratas , Proteínas Recombinantes de Fusión/fisiología , Sulfonamidas/farmacología , Acetato de Tetradecanoilforbol/farmacología , TransfecciónRESUMEN
Somatic mutations of the TSH receptor (TSHR) gene have been identified as the major cause of toxic thyroid adenoma. Recently, point mutations of the same gene have also been described in some differentiated thyroid carcinomas. The aim of the present study was to investigate the presence TSHR gene mutations in a series of thyroid specimens obtained from 22 consecutive patients with differentiated thyroid carcinomas (8 follicular and 14 papillary). Genomic DNA was extracted from fresh-frozen or paraffin-embedded tumor and normal surrounding parenchyma. Two fragments corresponding to the entire exon 10 and one fragment corresponding to exon 9 were amplified by PCR using biotinylated primers. PCR products were purified on streptavidin-coated magnetic beads and subjected to direct sequencing with Sequenase and 35(3)-labeled d-ATP-alphaS. Adenyl-cyclase activity in membrane preparations of 10 papillary carcinomas was also determined. No TSHR mutations were detected in these tumors. A polymorphism that encoded a single amino acid change Asp727Glu was identified in two follicular thyroid carcinomas. Adenyl-cyclase activity was normal in the ten papillary thyroid carcinomas we analyzed. In conclusion, our results suggest that clonal somatic mutations of the TSHR gene do not play a role in the pathogenesis of differentiated thyroid carcinoma.
Asunto(s)
Adenocarcinoma Folicular/genética , Carcinoma Papilar/genética , Receptores de Tirotropina/genética , Neoplasias de la Tiroides/genética , Adenocarcinoma Folicular/patología , Adenilil Ciclasas/metabolismo , Adolescente , Adulto , Sustitución de Aminoácidos , Carcinoma Papilar/enzimología , Carcinoma Papilar/patología , Membrana Celular/efectos de los fármacos , Membrana Celular/enzimología , Análisis Mutacional de ADN , Exones/genética , Femenino , Humanos , Masculino , Persona de Mediana Edad , Mutación/genética , Polimorfismo Genético/genética , Neoplasias de la Tiroides/enzimología , Neoplasias de la Tiroides/patología , Tirotropina/farmacologíaRESUMEN
The effect of melatonin and its precursor N-acetylserotonin was studied in a model of lipid peroxidation induced in human red blood cells by incubation with cumene hydroperoxide (CHP) and H2O2. The oxidative stress was expressed as vitamin E consumption in the presence of melatonin or N-acetylserotonin (concentration ranging from 0.3 to 400 microM): incubation with melatonin not only lacked any protective effect but it induced a dose-dependent extra vitamin E consumption with both CHP and H2O2. On the contrary, N-acetylserotonin showed a strong antioxidant effect at concentrations between 100 and 400 microM. The hydrogen-donating capacity of melatonin and N-acetylserotonin was also evaluated from the decay of the ESR signal of galvinoxyl radical used as hydrogen abstractor. Lack of hydrogen-donating capacity was observed with melatonin, whereas N-acetylserotonin showed a significant hydrogendonating capacity although inferior to vitamin E, thus suggesting that N-acetylserotonin acts by the classical antioxidant mechanism of hydrogen donation. The measurement of the oxidation potential and the specific molecular structure suggest that the vitamin E consumption effect observed with melatonin could be due to the interactions of its radical cation or derivatives on vitamin E.
Asunto(s)
Eritrocitos/efectos de los fármacos , Eritrocitos/metabolismo , Melatonina/farmacología , Serotonina/análogos & derivados , Vitamina E/sangre , Antioxidantes/farmacología , Derivados del Benceno/farmacología , Electroquímica , Espectroscopía de Resonancia por Spin del Electrón , Radicales Libres/sangre , Humanos , Peróxido de Hidrógeno/farmacología , Técnicas In Vitro , Peroxidación de Lípido/efectos de los fármacos , Modelos Biológicos , Oxidantes/farmacología , Oxidación-Reducción , Estrés Oxidativo/efectos de los fármacos , Serotonina/farmacologíaRESUMEN
Both hyperinsulinemia and free oxygen radicals have been implicated in the pathogenesis of atherosclerosis, but the relationship between insulin levels or insulin action and the oxidant/antioxidant balance has not been explored. We measured the effect of physiologic hyperinsulinemia on plasma concentrations of vitamin E, a major free radical scavenger molecule. Isoglycemic clamps (at an insulin infusion rate of 6 pmol . min-1 . kg-1) were performed in four groups of subjects: (1) 12 non-insulin-dependent diabetic (NIDDM) patients, (2) eight patients with essential hypertension, (3) 11 nondiabetic obese individuals, and (4) 12 healthy subjects. In 10 healthy volunteers, a time-control experiment was performed by replacing the insulin infusion with normal saline. Vitamin E and plasma lipid levels were determined at baseline and after 2 hours of insulin/saline infusion. Insulin sensitivity was reduced in diabetic, obese, and hypertensive groups in comparison to healthy controls, but fasting plasma vitamin E concentrations were similar in all groups. A consistent decrement in plasma vitamin E concentrations (averaging 12% of baseline, P < .0001) was observed in all subjects receiving insulin regardless of the level of insulin sensitivity, whereas no significant changes in plasma vitamin E were seen in subjects receiving saline infusion (P < .001 v insulin infusion groups). The insulin-induced decrement persisted in all study groups when plasma vitamin E concentrations were corrected for total serum cholesterol levels (-8.9% +/- 1.2% v -0.4 +/- 2.3% of saline controls, P = .0004) or serum low-density lipoprotein (LDL(-10.0% +/- 1.2% v -0.4% +/- 2.2%, P = .0002). We conclude that insulin infusion acutely depletes vitamin E in circulating lipids regardless of insulin resistance. This effect may represent a physiologic means of transferring vitamin E into cell membranes; alternatively, it might reflect a pro-oxidant action of insulin in vivo.
Asunto(s)
Insulina/farmacología , Vitamina E/sangre , Adulto , Colesterol/sangre , LDL-Colesterol/sangre , Femenino , Humanos , Resistencia a la Insulina , Lípidos/sangre , Masculino , Concentración OsmolarRESUMEN
Although a role for free radicals in myocardial damage during cardiopulmonary bypass for open heart surgery has been postulated, direct evidence of free radical production as well as consumption of tissue antioxidants such as vitamin E is still lacking. Twenty patients (age 26-66 yr, mean 48) undergoing elective open heart surgery with moderate hypothermia, and cold crystalloid cardioplegia, were studied. Cardiopulmonary bypass time was 61.4 +/- 31.2 min. The specimens of atrial tissue collection before and after cardiopulmonary bypass, were immediately frozen in liquid nitrogen. Mean vitamin E atrial content, measured by reverse phase HPLC, was 355 +/- 249 pmol/mg of dry weight basally, 135 +/- 85 pmol/mg (p < 0.05) at the end of the ischemic period and 405 +/- 288 pmol/mg after the reperfusion period (p < 0.01). Microscopic examination of right atrial biopsies ruled out differences in fibrosis or cellular damage as the cause of vitamin E changes. Although a great basal variability in atrial vitamin E content was observed, which was independent of age, sex and clinical status, a reproducible and substantial decrease in atrial vitamin E content after cardiopulmonary bypass occurred (mean reduction 45 +/- 17% and 55 +/- 22%, respectively, after ischemia and after reperfusion). This was directly related to the aorta cross-clamping duration and partially to the minimum temperature achieved. In conclusion, apart from the great variability observed in basal vitamin E tissue content, vitamin E was always reduced during cardiopulmonary bypass, suggesting an oxidative stress on the myocardium during open heart surgery.
Asunto(s)
Puente Cardiopulmonar/efectos adversos , Atrios Cardíacos/química , Complicaciones Intraoperatorias/metabolismo , Isquemia Miocárdica/metabolismo , Vitamina E/química , Adulto , Anciano , Biopsia , Cromatografía Líquida de Alta Presión , Femenino , Radicales Libres/química , Radicales Libres/metabolismo , Atrios Cardíacos/metabolismo , Humanos , Complicaciones Intraoperatorias/patología , Complicaciones Intraoperatorias/cirugía , Masculino , Persona de Mediana Edad , Isquemia Miocárdica/patología , Isquemia Miocárdica/cirugía , Factores de Tiempo , Vitamina E/metabolismoRESUMEN
Detection of ultraweak chemiluminescence (CL) emission from the surface of the organ is a sensitive and non-disruptive tool to evaluate the oxidative stress in rat heart. Indeed, an increased photon emission rate can be observed when cellular antioxidants such as glutathione or vitamin E are depleted, or when organic hydroperoxides are infused. We used CL recording to demonstrate in rat heart that: (i) different diets may lead to different heart sensitivity to an oxidative stress; and (ii) post-ischaemic reoxygenation induces an oxidative stress. CL emission induced by an oxidative stress is accompanied by an increased release of eicosanoids. However, while non-steroid anti-inflammatory drugs (aspirin, indomethacin and ibuprofen) prevented eicosanoid release, these compounds dramatically enhanced hydroperoxide-dependent CL. The nature of this phenomenon is still obscure, but the increase of steady-state concentration of excited species caused by anti-inflammatory drugs seems to be pathophysiologically relevant, since in all our experimental conditions tissue damage was proportional to CL emission rate.
Asunto(s)
Mediciones Luminiscentes , Miocardio/metabolismo , Animales , Antiinflamatorios no Esteroideos/farmacología , Enfermedad Coronaria/metabolismo , Ácidos Grasos Insaturados/metabolismo , Técnicas In Vitro , Oxidación-Reducción , Perfusión , Peróxidos/farmacología , Ratas , Estrés Fisiológico/metabolismo , Vitamina E/metabolismoRESUMEN
Aim of this study was to confirm an increased free radical generation rate during ischemia-reoxygenation, by ultra-weak chemiluminescence detection at the surface of perfused rat heart. We observed that reoxygenation following 30 min global ischemia, induces an increase of ultraweak chemiluminescence emission in isolated perfused heart only if partial depletion of vitamin E is induced by dietary manipulation. Moreover, in normal diet fed rats, vitamin E is partially consumed during global ischemia, but not during reoxygenation. Since chemiluminescence increases during post-ischemic reperfusion, when vitamin E myocardial content is lowered, the most probable free radicals involved are the hydroperoxyl radical derivatives of lipids. These radicals, indeed, are known both to produce photoemission by disproportion and to react with vitamin E. On the other hand, the nature of the reaction that consumes vitamin E during ischemia is still obscure. Accordingly, the basal level of vitamin E myocardial content seems to be a key factor for protecting the heart against reoxygenation injury and its consumption during ischemia could be a determinant of myocardial sensitivity to oxidative stress during reperfusion.
Asunto(s)
Reperfusión Miocárdica , Miocardio/metabolismo , Deficiencia de Vitamina E/metabolismo , Animales , Ácido Ascórbico/farmacología , Enfermedad Coronaria/metabolismo , Corazón/efectos de los fármacos , Mediciones Luminiscentes , Masculino , Ratas , Ratas Endogámicas , Valores de Referencia , Vitamina E/farmacologíaRESUMEN
The effect of diets supplemented with three different fats (olive oil, sunflower oil, pork fat) on the susceptibility of the rat heart to oxidative stress and on the rate of eicosanoid release were studied. Our results show that when fatty-acid unsaturation of heart lipids is increased or vitamin E is decreased, even to a low degree, a marked enhancement of the susceptibility to hydroperoxide-induced oxidative stress (measured by chemiluminescence emission) occurs, which is associated with an increase of eicosanoid release from the heart.
Asunto(s)
Grasas de la Dieta/farmacología , Ácidos Eicosanoicos/metabolismo , Miocardio/metabolismo , Peróxidos/metabolismo , Animales , Derivados del Benceno/farmacología , Ácidos Grasos Insaturados/metabolismo , Corazón/efectos de los fármacos , Cinética , Mediciones Luminiscentes , Ratas , Vitamina E/metabolismoRESUMEN
There are marked differences between human cardiomyopathies, especially of the hypertrophic variety, and animal models. There is no simple way in which a hyperadrenergic state can explain the contractile abnormalities, although additional effects of calcium overload or marked hypertrophy come somewhat closer to linking animal and human diseases. One of the best links between excess catecholamine stimulation and myocardial damage lies in the enhanced sarcolemmal permeability which is mediated by beta-adrenergic stimulation and calcium ions in an isolated rat heart model. The therapeutic success of beta-adrenergic blockade and especially calcium antagonists in no way provide firm evidence for a hyperadrenergic state nor for intracellular calcium overload. In human hypertrophic cardiomyopathy, these agents may be acting merely by enlarging cavity size. In dilated cardiomyopathy, the use of beta-adrenergic blockers is still highly controversial and calcium antagonists are not well tested. It is the lack of appropriate models for both hypertrophic cardiomyopathy and dilated cardiomyopathy which is holding up research in this important area.
Asunto(s)
Antagonistas Adrenérgicos beta/uso terapéutico , Bloqueadores de los Canales de Calcio/uso terapéutico , Calcio/metabolismo , Cardiomiopatías/metabolismo , Catecolaminas/metabolismo , Adrenocromo/metabolismo , Animales , Transporte Biológico Activo , Calmodulina/fisiología , Cardiomiopatías/tratamiento farmacológico , Cardiomiopatías/fisiopatología , Cardiomiopatía Dilatada/tratamiento farmacológico , Cardiomiopatía Dilatada/metabolismo , Cardiomiopatía Dilatada/fisiopatología , Cardiomiopatía Dilatada/veterinaria , Cardiomiopatía Hipertrófica/tratamiento farmacológico , Cardiomiopatía Hipertrófica/metabolismo , Cardiomiopatía Hipertrófica/fisiopatología , Gatos , Cricetinae , AMP Cíclico/fisiología , Modelos Animales de Enfermedad , Fibrosis Endomiocárdica/metabolismo , Fibrosis Endomiocárdica/fisiopatología , Insuficiencia Cardíaca/metabolismo , Ventrículos Cardíacos/fisiopatología , Humanos , Mesocricetus , Modelos Biológicos , Receptores Adrenérgicos/metabolismo , Receptores de Catecolaminas , Enfermedades de los Roedores/genética , Enfermedades de los Roedores/fisiopatología , Sarcolema/metabolismoRESUMEN
Mitochondria were prepared from the subendocardial and subepicardial layers of the canine left ventricle. The oxidation rates of palmitate, palmitoyl carnitine and pyruvate of the mitochondria obtained from the two cardiac layers were measured. The cytochrome content and the specific activities of different beta oxidation and Krebs cycle enzymes were also measured in the two mitochondrial populations. Mitochondria isolated from the ENDO layer showed significantly higher oxidation rates than mitochondria from the EPI layer for all the three substrates. No statistically significant differences in cytochrome c+c1 and a+a3 content were found in mitochondria isolated from the two regions. No significant transmural differences were found in fatty acyl CoA, L-3-hydroxy fatty acyl CoA, succinic and malic dehydrogenase specific activities, whilst isocitric dehydrogenase (NADP) specific activity was significantly higher in mitochondria isolated from the inner layer. In conclusion, the mitochondria isolated from the inner left ventricular layer of the canine heart show a higher oxidative capacity than subepicardial mitochondria. This difference could partly be explained by the higher specific activity of isocitric dehydrogenase in this layer. These properties of subendocardial mitochondria could represent a metabolic support for the greater contractile performance of this layer.
Asunto(s)
Mitocondrias Cardíacas/metabolismo , Animales , Citocromos/metabolismo , Perros , Endocardio/metabolismo , Ventrículos Cardíacos/metabolismo , Técnicas In Vitro , Isocitrato Deshidrogenasa/metabolismo , Consumo de Oxígeno , Pericardio/metabolismo , Piruvatos/metabolismo , Ácido Pirúvico , Distribución TisularRESUMEN
Diamide, CDNB and phorone were used to deplete glutathione in retrogradely perfused rat hearts. Following glutathione depletion the spontaneous chemiluminescence increased by 70%, irrespective of the agent used. The glutathione depletion and the chemiluminescence emission were associated to an increase of malondialdehyde content in the heart, as determined by HPLC. Under these conditions the heart function was impaired and histological examination showed a coagulative myocytolysis, a pattern already described in human and experimental pathology, where a key role is attributed to a Ca2+ homeostasis impairment.
Asunto(s)
Glutatión/fisiología , Peróxidos Lipídicos/metabolismo , Mediciones Luminiscentes , Miocardio/metabolismo , Animales , Diamida/farmacología , Dinitroclorobenceno/farmacología , Corazón/efectos de los fármacos , Técnicas In Vitro , Cetonas/farmacología , RatasRESUMEN
The isolated perfused rat heart emits a spontaneous ultraweak chemiluminescence. When the perfusion is stopped, light emission decreases, indicating the dependency of this phenomenon on aerobic metabolism. Emitted chemiluminescence was markedly enhanced following perfusion with 0.05 mM H2O2 or cumene hydroperoxide or tert-butyl hydroperoxide; substitution of O2 for N2 in the gassing mixture of the perfusion media significantly lowered photon emission. Lipid peroxidation, which is known to be associated with chemiluminescence, was evaluated by HPLC analysis of peroxidized and unperoxidized heart phosphatidylcholines. During hydroperoxide perfusion, coronary flow and heart rate progressively decreased, while lactic dehydrogenase was released after complete cardiac arrest. The resultant morphology of this damage corresponds to the so-called 'stone heart', a pattern already described in both human and experimental pathology.